J.W.B. D. G.
- Country
- The Netherlands
- Department
- Medische Oncologie
Research Overview
- Evaluation of Hepatic Arterial Infusion of Floxuridine with Systemic Therapy in Unresectable Colorectal Liver Metastases: A Randomized Controlled Trial
- Evaluation of Regorafenib, Vemurafenib, and Dacomitinib in Advanced Solid Tumors, Multiple Myeloma, and Non-Hodgkin Lymphoma with Targetable Genomic Variants
- Efficacy of Adjuvant Hepatic Arterial Infusion of Floxuridine Post-Resection in Low-Risk Resectable Colorectal Liver Metastases: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 33 of 54 partner sites.
Specializations
Pancreatic Cancer Research
The investigator focuses on treatment optimization for patients with metastatic pancreatic cancer, particularly exploring the timing of therapeutic interventions. Their research examines the impact of treatment initiation strategies on patient outcomes.
- Asymptomatic Metastatic Disease Management
- Treatment Timing Strategies
- Quality-Adjusted Survival Assessment
Esophageal Cancer Treatment
Specializing in innovative approaches for esophageal squamous cell carcinoma, the investigator studies combination therapies including immunotherapy and chemoradiation. Their work encompasses treatment modalities for both localized and advanced disease.
- Combined Modality Treatment
- Immunotherapy Integration
- Chemoradiation Protocols
Gastrointestinal Oncology
The investigator conducts research in advanced esophagogastric cancer treatment, evaluating novel therapeutic combinations. Their work includes studying innovative chemotherapy formulations and comparing different treatment regimens.
- First-line Treatment Strategies
- Novel Drug Formulations
- Progression-Free Survival Studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.